Impact of a national mesothelioma network on outcomes including survival

July 13, 2026 | Comments Off on Impact of a national mesothelioma network on outcomes including survival

Thorax 2026 May 8 [Link] Matthew Tate, Joshua Joseph Roche, Selina Tsim, Neil McGlinchey, Katie Ferguson, Phil Reid, Philip Short, Mahendran Chetty, Clinton Ali, Noelle O’Rourke, Carol MacGregor, Carolyn MacRae,…

Real-world outcomes of multimodal treatment for pleural mesothelioma: A retrospective study in a high-volume integrated regional center

July 10, 2026 | Comments Off on Real-world outcomes of multimodal treatment for pleural mesothelioma: A retrospective study in a high-volume integrated regional center

JTCVS Open 2026 January 30 [Link] Alison S Baskin, Keza Levine, Yun-Yi Hung, Elaine Liang, Kian C Banks, J Marie Suga, Jeffrey B Velotta Abstract Objective: To evaluate overall survival…

BAP1 and USP1 cooperate to regulate FANCD2 stability and cell proliferation in mesothelioma cells

July 9, 2026 | Comments Off on BAP1 and USP1 cooperate to regulate FANCD2 stability and cell proliferation in mesothelioma cells

Cell Death & Disease 2026 May 2 [Link] Koya Suzuki, Shinichi Kiyonari, Jo Nishino, Miki Takahashi, Yuna Kato, Miki Amano, Anna Ogiso, Tomohiro Akashi, Tohru Maeda, Norio Kaneda, Takashi Miida,…

Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma

July 8, 2026 | Comments Off on Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma

Lung Cancer 2026 July [Link] Miyu Kano, Aki Furusawa, Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Hiroshi Yamamoto, Peter L Choyke, Hisataka Kobayashi Abstract Malignant pleural mesothelioma (MPM) is a rare,…

Cellular Plasticity in Malignant Transformation: Mesothelial Cells

July 7, 2026 | Comments Off on Cellular Plasticity in Malignant Transformation: Mesothelial Cells

Pathobiology 2026 April 29 [Link] Claire W Michael, Ben Davidson Abstract Background: Mesothelial proliferations range from reactive lesions to benign and malignant tumors, bearing witness to the plasticity of these…

Cellular Plasticity in Malignant Transformation: Mesothelial Cells

July 6, 2026 | Comments Off on Cellular Plasticity in Malignant Transformation: Mesothelial Cells

Pathobiology 2026 April 29 [Link] Claire W Michael, Ben Davidson Abstract Background: Mesothelial proliferations range from reactive lesions to benign and malignant tumors, bearing witness to the plasticity of these…

Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report

July 3, 2026 | Comments Off on Paraneoplastic Brachial Amyotrophic Diplegia and Encephalitis With Ma2-IgG During Immune Checkpoint Inhibitor Use for Mesothelioma: A Case Report

JTO Clinical and Research Reports 2026 March 6 [Link] Sanem Pinar Uysal, Shervin Badihian, Karlo Toljan, Nirmal Andrapalliyal, James Stevenson, Jonathan Lee, Amy Kunchok Abstract Background: Immune checkpoint inhibitors (ICIs)…

Immunotherapy resistance and strategies in malignant pleural mesothelioma

July 2, 2026 | Comments Off on Immunotherapy resistance and strategies in malignant pleural mesothelioma

Cancer Drug Resistance 2026 March 26 [Link] Wanyi Xia, Yulong Zhang, Juanzhi Zhao, Xiaoli Tan, Shaolong Ju, Wei Zou, Chaoqun Chen, Chunwei Li, Yanghua Xu, Yingming Peng, Shengqiao Li Abstract…

Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma

July 1, 2026 | Comments Off on Multiplexed single-cell and spatial profiling reveal B cells and tertiary lymphoid structures as prognostic indicators in pleural mesothelioma

British Journal of Cancer 2026 July [Link] Angelica Rigutto, Nicolás G Núñez, Jenny C Kienzler, Isabelle Opitz, Mayura Meerang, Martina Haberecker, Nadine Fournier, Joao Lourenço, Raphael Gottardo, Karina Silina, Anurag…

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

June 30, 2026 | Comments Off on Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Nature Genetics 2026 May [Link] Luana Calabrò, Francesca P Caruso, Alessia Covre, Teresa M R Noviello, Maria F Lofiego, Rossella Tufano, Luigi Ferraro, Piera Grisolia, Antonio De Falco, Vincenzo Lagano,…

Categories